Nausea from GLP-1 medication: causes and what you can do

Nausea is the most commonly reported side effect of GLP-1 medications. Whether you’re using Ozempic, Wegovy, Saxenda or Mounjaro, stomach upset during the first few weeks of treatment is something many people can relate to. In this article, you can read why this happens, how long it might last, and what changes to your diet and habits can make a difference.

Why do GLP-1 medications cause nausea?

GLP-1 agonists work by activating GLP-1 receptors in the gastrointestinal tract and the brain. One of the effects is that gastric emptying is delayed: food stays in the stomach longer, which means you feel full sooner and eat less. This delay is beneficial for weight loss, but at the same time it is the direct cause of nausea, bloating and sometimes vomiting. The body interprets the delayed gastric emptying as a signal that something is not right, especially at the start, when it is not yet accustomed to the drug’s effects.

The STEP 1 study showed that nausea with semaglutide 2.4 mg occurred in just over 44% of participants. The good news: clinical studies show that only 4.5% discontinued treatment due to gastrointestinal side effects. For most people, these side effects are mild to moderate and clearly subside the longer the treatment continues.

When is the nausea at its worst?

Nausea usually occurs in the first few days to weeks following a dose increase. With semaglutide and tirzepatide, which are injected weekly, the day after the injection can be a little tougher. With liraglutide (Saxenda), which is taken daily, the pattern is continuous, but you also get used to it more quickly. As the dose stabilises and the body gets used to the medicine’s effects, the nausea subsides significantly in most people.

The titration schedule for GLP-1 medicines is designed with gradual steps for a reason. By gradually increasing the dose, the body is given time to adjust. Read more about how it works on the Wegovy page at Goodweigh. If you still experience persistent discomfort, discuss with your healthcare professional whether a longer intermediate step is advisable.

What can you eat to reduce nausea?

Your diet has a major influence on how you feel during treatment. Fatty, heavy or strongly spiced meals further delay gastric emptying, which increases the risk of nausea. Small, light meals spread throughout the day work better than three large portions. Eat slowly, chew well and stop when you are full, even if the portions are smaller than you are used to.

An expert consensus from international specialists emphasises that practical adjustments to diet and lifestyle can significantly reduce nausea caused by GLP-1 medication. Specifically, it helps to choose foods that are easy to digest: steamed vegetables, rice, soup, and cooked meat. Avoid fizzy drinks, alcohol, and fast-acting sugars during the first few weeks of treatment or immediately after a dose increase. You can find more information on what works well when using GLP-1 in the article on what to eat when using GLP-1 medication.

When should you contact your doctor?

Mild nausea is a normal and expected part of the treatment. However, there are situations where you should contact a doctor. This applies if you are so nauseous that you can no longer eat or drink, if the vomiting persists for several days, if you experience signs of dehydration such as a dry mouth, infrequent urination or dizziness, or if you have severe abdominal pain in the upper abdomen or back. The latter may be a sign of acute pancreatitis, a rare but serious side effect that can occur with all GLP-1 medicines.

A recent review of nausea as a side effect of GLP-1 medicines confirms that side effects in most users are manageable and subside during treatment, but that medical supervision remains essential in the event of more serious symptoms. At Goodweigh, you always have access to your treating doctor should side effects occur.

Does nausea vary from one medicine to another?

All GLP-1 medicines have a comparable side-effect profile regarding the stomach and intestines, but there are nuances. Liraglutide (Saxenda) has a shorter half-life and is injected daily, which means you get used to it more quickly, but also have to deal with a new injection site every day. Semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) are injected weekly and have a longer half-life, which makes the effect more consistent, but the transition when increasing the dose may feel slightly more pronounced.

In addition to the GLP-1 receptor, tirzepatide also activates the GIP receptor. In the SURMOUNT trials, tirzepatide had a comparable GI profile to semaglutide for the same weight loss, with nausea and diarrhoea being the most common side effects. For an overview of all available medicines, visit Goodweigh’s page on weight-loss medicines.

Nausea as a sign, not a reason to stop

Nausea with GLP-1 medicines is unpleasant, but it is also a sign that the medicine is working. The body is adapting to a new way of functioning. For most people, it disappears within a few weeks, especially if the dose remains stable. Don’t be put off by the first few weeks: the chance of significant weight loss has been proven, and the side effects are temporary for most people.

If you are unsure whether treatment with GLP-1 medication is right for you, or if you want to know whether you are eligible for it, you can read the overview article on when you are eligible for GLP-1 medication. You can also book an initial consultation with Goodweigh straight away, during which the doctor will assess your situation and draw up a personalised treatment plan.

‍

‍

‍